Cyclin-Dependent Kinase 4/6 Inhibitors in Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer: Efficacy, Safety, and Clinical Integration. CDF. 2024;53(03):6759-6769. doi:10.48047/xjqvkf88